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Abstract 
Objective: To assess the association between intrapartum intrathecal opioid use and breastfeeding and 
weight gain following cesarean section.  
Materials and methods: The prospective double-blinded study was conducted on term pregnant women, 
undergoing elective cesarean section under spinal anesthesia. They divided into two groups. In the first 
group, intrathecal Morphine was used to achieve analgesia during or after the operation. The remainder 
divided into two subgroups, those who did not receive any opioid or those received systemic opioids. 
Following labor breastfeeding accessed in a follow-up, two month latter. 
Results: There was no difference between the demographic variables of the mothers and newborns 
APGAR score and weight at the time of birth. Breastfeeding rate was similar in intrathecal group in 
compare with other patents (P value = 0.518). While, the infants’ weight at the end of second month 
was lower in spinal opioid group (P value = 0.036). 
Conclusion: The present study was the first to suggest that spinal (intrathecal) opioids do not have any 
impact on breastfeeding. However the relationship between spinal anesthesia on weight gaining needs 
more investigation. 
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Introduction 
Breastfeeding difficulties in the early postpartum 
period, especially if combined with inadequate 
support and advice, may cause new mothers give up 
nursing their babies. 
Many factors, including demographic, biological, 
social, and psychological variables are influencing 
breastfeeding. Race, age, marital status, education, 
socioeconomics, and supplemental nutrition 
programs, maternal obesity, physical challenges of 
breastfeeding like sore nipples, engorgement, milk 
insufficiency, maternal smoking, parity, delivery 
method, occupation, family and professional supports 
are all known to affect breastfeeding process and 
pattern. Several other factors like; maternal intention, 
interest, and confidence to breastfeeding, parity, 
infant status, poor newborn weight gain, difficulty of 
the newborn in latching onto the breast or sucking, 
infant being demand fed in hospital, discontented 
baby as well as the type of labor and birth, and even 
other family member preference for breastfeeding may 
influence the establishment of breastfeeding (1-6). 
In addition, the literature has identified the use of 
pain medication by the mother during labor to 
influence breastfeeding success (7, 8). There are 
controversial reports regarding the effects of pain 
relief medication on neonatal breastfeeding duration 
(7-12). 
Initial studies in this regard, however, mainly 
focus on the impact of epidural opioid analgesics on 
the newborn’s growth rate and neurobehavioral; 
which are considered to have a significant influence 
in reducing the breastfeeding rate (13-16). However 
more recent studies are discussing safety of regional 
anesthesia and intrathecal opioids on breastfeeding 
(17-19).  
Considering the fact that the majority of the 
available studies have focused on women receiving 
epidural analgesics, and regarding the popularity of 
spinal anesthesia to perform cesarean section; this study 
aimed to determine whether there is any association 
between intrathecal opioid use on breastfeeding 
following cesarean section under spinal anesthesia. 
Materials and methods 
Approved by the Ethical Board Committee of Tehran 
University of Medical Sciences, ethical number  
7714-300188, this prospective double-blinded study 
was conducted in Women Hospital (certified as Baby 
Friendly Hospital Initiative (BFHI) -- a worldwide 
program of the World Health Organization and 
UNICEF --). All term (gestational age ≥ 37 week) 
pregnant women undergoing elective or emergency 
Cesarean Section under spinal anesthesia who had 
consent to be included in the study, and hadn’t 
received opioids within a month before the procedure 
were included. 
Patients with previous history of head trauma in 
need of hospital administration or neurologic 
disorders along with those experiencing severe pre-
eclampsia, and other medical conditions leading to 
Intrauterine Growth Retard (IUGR) as well as those 
who had been treated for infertility were excluded 
from the study. Mothers who had a history (even a 
suspicious history) of addiction, alcohol or stimulant 
drug consumption, smoking history, along with those 
taking anti-convulsive medication, antidepressants 
and tranquillizers were also excluded from the study. 
Women with endocrinologic disorders, history of 
breast anomalies and/or surgery as well as other 
underlying causes such as a history of postpartum 
depression interfering with breastfeeding were also 
excluded. Women with a previous history of breast 
operation or suffering from any surgical or 
anesthesiologic complication and those whose infants 
were Low Breath Wight (LBW), had a 5’th minute 
Apgar lower than 8 or admitted to Neonatal Intensive 
Care Unit (NICU) were excluded from the study. 
Other probable confounders including; mother’s age, 
weight, Body Mass Index, gestational diabetes, 
smoking, occupation, education, Obstetric and 
pregnancy history, breastfeeding history, number of 
children, and also infants 1’th and 5’th minutes 
Apgar, weight, and sex, were recorded. 
If the woman received any systemic (intravenous, 
intramuscular, transcutaneous, or inhalational) 
anesthetic medications during labor, was no more 
eligible to participate in the study. 
All the patients signed an informed consent before 
entering the study. The patients were primarily 
divided into two groups using computerized random 
software. In the first group, intrathecal Morphine 
(Morphine Sulfate, Darou Pakhsh Co.) (5µg/kg 
intrathecaly [minimum 300μg and maximum 500μg]) 
was used to achieve analgesia during or after the 
operation. After the operation, however, no systemic, 
neuraxial or local opioids or even other analgesic 
non-opioids were administered. Patients who  
need other analgesic medication considered to be  
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excluded latter. 
The control group received no neuraxial or local 
opioids during or after the operation. In this group, 
non-opioids including Non- Steroidal Anti-
Inflammatory Drugs (NSAID's) or acetaminophen 
was used as first choice of analgesia. A subgroup of 
control group who had experienced a resistant pain, 
had received doses of pethidine (20-50 mg) 
(Pethidine, Caspian Tamin) or fentanyl (50-100 μg) 
(Fentanyl Citrate, Caspian Tamin) -only in the 
operating or recovery room just after operation-, to 
relive pain. The patients who needed more than 100 
mg pethidine because of their excessive pain 
considered to exclude from the study. 
Spinal anesthesia was performed in sitting position 
using a 27 Gauge Quinke spinal needle (Dr. Japan Co. 
Ltd) through L4-L5 or L5-S1 levels. In these cases,  
12-15 mg hyperbaric Bupivacaine Hydrochloride 0.5% 
(Marcaine Spinal 0.5%, Heavy, AstraZeneca) was 
used as anesthetic during the operation. 
All the patients received 2 mg midazolam 
following the clamping of the umbilical cord. No other 
sedative prescribed in any of the patients. Oxytocin 
(Oxytip
®
, Caspian Tamin) 30 units in 2 hours was 
administered in all patients. All other medications 
(antibiotic prophylaxis) and treatments (out of bed, 
Foley catheter) were performed according to hospital 
protocols. The demographic and gynecologic 
characteristics of the subjects recorded and compared 
between groups. The newborn was visited by a 
pediatrician and his/her general condition as well as 
the 1 and 5 minute APGAR score were assessed. The 
fact whether he or she was transferred to NICU or 
neonatal high-risk wards was also recorded. 
The conditions which may interfere with the 
nursing process and the medication taken by the 
mother were recorded.  
All mothers were unaware of the group to which 
they were allocated. The mothers were encouraged 
and taught how to breastfeed their newborns 
according to BFHI points. Mother and child contact 
started in operation theater for all mothers. As a 
routine program, an experienced, educated 
breastfeeding nursing group, unaware of the 
objectives of the study, was responsible for teaching 
the technique through a face-to-face education and 
follow-up the successful in-hospital breastfeeding. 
The mothers were then asked at the time of discharge 
to see whether their baby had any problems with 
breastfeeding or not. There was an additional 
assessment of breast-feeding by a member of the team, 
blinded to group assignment, at 8 weeks postpartum. 
The team member called all the mothers at 65-75 
days postpartum to determine whether they were still 
breast-feeding. If the mother was not breast-feeding, 
she was queried as to whether this was related to 
difficulty the infant was experiencing with breast-
feeding or not. Baby weight, the neonate and mother 
health condition, used medications, any hospital 
administration, and the mother’s tendency toward 
breastfeeding were asked during this call. Individuals 
experiencing conditions which interfere with 
breastfeeding, including baby or mother disease or 
hospital administrations,  mastitis and postpartum 
depression, or any condition that interfere with their 
normal contact, and mothers who did not like to 
breastfed their babies considered to be excluded from 
the study. The consumption of any herbal or home 
ordered food additives or traditional medication used 
as breastfeeding supporters was recorded. Those who 
did not answer to call for 4 repeated calls in next days 
also were excluded. 
Sample Size: Considering the study conducted by 
Jordan et al, the prevalence of breastfeeding in the 
control group along with women taking neuraxial and 
systemic opioids was 32%, 52% and 41% (20). By 
considering the values for neuraxial opioids in 
compare with mean values of other two groups, the 
power analysis demonstrated that a sample size of 
128 in each group, which would be sufficient to 
provide 80% power to detect less than 15% 
difference between the groups. 
Statistical Analysis: The gathered data were 
analyzed using SPSS software version 17. Data were 
explored with t tests and crosstabs as appropriate.  
P-values lower than 0.05 were considered as 
significant. In a logistic regression model for 
comparing two groups adjusted on possible 
confounders, the validity of finding accessed. 
Results 
From among 435 women who recruited in this study, 
only 250 fulfilled the inclusion criteria.  Mothers who 
received both spinal and systemic opioids (6), those 
who gave birth to their infant before 37-40 weeks of 
gestation , their infant suffered from low birth weight 
(< 2500 g) (12), or their infant was admitted in NICU 
(11), and mothers whose contact numbers were 
wrong or changed, those who refused to breastfeed 
their child or answer our calls, or had postpartum 
conditions which interfere with normal breastfeeding, 
were excluded from the study (n=116) (Figure 1). 
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Figure 1: CONSORT chart of the study 
 
We enrolled 250 women with the mean age of 
28.07 years, ranging from 17 to 46 years. Table 1 
outlines the demographic data of the studied subjects. 
There was no significant difference between the ages 
of the studied mothers in the two groups. 
About 90.4% of the studied mothers were reported 
to be housewives. Only 11.3% of the studied mothers 
had attended college. 29.3% of the subjects were 
primary gravid, whereas others were experiencing 
their second to sixth pregnancy. They had between 1 
(35.1%) and 4 (0.4%) children. About 47.6% of them 
had breastfed their older children. 
 
Table 1: comparing quantitative variables between spinal and non-spinal groups 
Variables 
Group 
P-value Spinal Nonspinal 
Mean ± (Standard Deviation) Mean ± (Standard Deviation) 
Mother Age (year) 28.56 ± (5.58) 27.83 ± (5.05) 0.305 
Mother Weight (kg) 77.87 ± (13.70) 76.43 ± (12.74) 0.421 
Mother Height (cm) 161.51 ± (5.52) 160.24 ± (6.15) 0.122 
Mother BMI
*
 (kg/m
2
)
 
29.80 ± (4.70) 29.83 ± (4.77) 0.960 
Gravid 2.10 ± (0.94) 2.22 ± (1.08) 0.401 
Para 1.94 ± (0.85) 2.08 ± (0.93) 0.230 
Number of Children 0.96 ± (0.88) 1.10 ± (0.94) 0.288 
Pregnancy Age (year) 38.61 ± (1.11) 38.85 ± (1.24) 0.151 
APGAR in 1 minute 8.94 ± (0.37) 8.96 ± (0.23) 0.602 
APGAR in 5 minute 10.00 ± (0.00) 9.98 ± (0.17) 0.351 
Weight of Neonate (g) 3206.87 ± (389.09) 3227.73 ± (430.40) 0.715 
Lactogenic Medication 1.51 ± (0.50) 1.57 ± (0.50) 0.413 
Weight of Neonate at 2 month age (g) 5048.73 ± (962.93) 5295.48 ± (803.95) 0.036 
*Body Mass Index 
435 women who 
recruited in this study 
250 cases fulfilled the inclusion 
criteria 
Six mothers received both 
spinal and systemic 
opioids and excluded 
Forty mothers gave birth to 
their infant before 37 weeks 
of gestation were excluded 
Twelve who their infant 
suffered from low birth 
weight (< 2500 g) were 
excluded 
Eleven their infant was 
admitted in NICU were 
excluded 
116 mothers whose contact numbers were wrong or 
changed, those who refused to breastfeed their child 
or answer our calls, or had postpartum conditions 
which interfere with normal breastfeeding, were 
excluded from the study. 
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Table 2: comparing categorical variables between spinal and non-spinal groups 
Variables 
 Spinal Nonspinal 
P-value* 
 Count (%) Count (%) 
Job Housewife 74(92.5%) 152 (89.4%) 0.499 
Education grad Primary school 22 (27.8%) 65 (38.7%) 0.228 
Primary to high school 48 (60.8%) 84 (50.0%0 
University 9 (11.4%) 19 (11.3%) 
Breastfeeding History 35 (43.8%) 84 (49.4%) 0.419 
Gender of Neonate Male 44 (55.0%) 87 (51.2%) 0.590 
Female 36 (45.0%) 83 (48.8%) 
Ward Mothers 72 (90.0%) 142 (83.5%) 0.246 
High Risk 8 (10.0%) 28 (16.5%) 
Diabetes mellitus or Gestational Diabetes 6 (7.5%) 15 (8.8%) 0.811 
Lactogenic medication 39 (48.8%) 72 (42.6%) 0.413 
Feeding rout in two month age Breastfeeding 54 (67.5%) 121 (71.2%) 0.725 
formula 4 (5.0%) 10 (5.9%) 
Combination of Breastfeeding and formula 22 (27.5%) 39 (22.9%) 
Completely formula feeding in two month age 4 (5.0%) 10 (5.1%) 0.518 
*chi square test was used 
 
There were 131 (52.4%) boys and 119 (47.6%) 
girls among the newborns. The weight of the babies 
ranged between 2500 and 4700 g. Infants born to 
14.4% of the women were admitted in the neonatal 
high-risk ward. There was no significant difference 
between the age, Body Mass Index (BMI) and gravid 
of the mothers allocated in each group (P-value > 0.05). 
As for the infant, similarly, the 1
st
 and 5
th
 min 
APGAR, and weight at the time of birth was not 
statistically different in their groups (P-value > 0.05) 
(Tables 1 and 2). 
Among studied women, 14 (5.6%) did used 
formula completely to feed their newborn at 2 months 
after breath. 175 (70%) of them breastfed their 
children whereas 61 of them (24.4%) gave their 
children baby formulas or a combination of breast 
milk and baby. These feeding routes were not 
statistically different significantly between those who 
had received spinal opioids and those without spinal 
opioids (P-value = 0.725), as regarding complete 
formula feeding two months after cesarean section  
(P-value = 0.518).  But the infants weight at the 2nd 
month was significantly different between those who 
had received spinal opioids and those without spinal 
opioids (P-value = 0.036) (Tables 1 and 2). 
There was no significant difference between the 
opioid analgesics administration route (spinal 
opioids, systemic opioids or none) and the rate of 
breastfeeding in the mothers, also (P-value = 0.773). 
About 111 (44.6%) of the mothers reported the use of 
different medications for increasing their milk during 
the one month follow up interval which was 
distributed similarly in two groups of study  
(P-value = 0.413). 
Considering Feeding at two month of age (solely 
Breastfeeding or combination feeding as the event vs. 
formula) as the dependent variable; In multivariate 
analysis using Logistic Regression for adjusting 
factor consisting of Mother Age, BMI, Job, 
Education, Pregnancy Age, Breastfeeding History, 
Sex, 1 minute and 5 minute APGAR, Neonatal 
weight at birth, and Lactogenic medications; finally 
Sex (male to female) (P = 0.105; OR = 0.33; 95%  
CI 0.88- 1.26), and lactogenic medications (yes to no) 
(P = 0.064; OR = 0.28; 95% CI 0.07- 1.07) were 
remained in the model (Table 3). 
 
Table 3: Independent variables which affect feeding at two month of age 
 P-value Odd Ratio 95% CI (confidence interval) 
neonate gender 0.105 0.33 0.88-1.26 
lactogenic medications use 0.064 0.28 0.07-1.07 
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Table 4: Independent variables which affect neonatal weight at two month of age 
 P-value β 95% CI (confidence interval) 
Spinal vs. non-spinal anesthesia 0.009 327.12 84.08- 570.15 
neonatal weight at birth 0.000 0.75 0.47- 1.03 
lactogenic medications use 0.020 -276.99 43.51- 510.48 
 
Considering neonatal weight at two month age as 
the dependent variable; In multivariate analysis using 
ANCOVA for adjusting factor consisting of Mother 
Age, BMI, Job, Education, Pregnancy Age, 
Breastfeeding History, Sex, 1 minute and 5 minute 
APGAR, Neonatal weight at birth, and Lactogenic 
medications; finally type of intervention (Spinal vs. 
non-spinal anesthesia) (P = 0.009; β = 327.12; 95% 
CI 84.08- 570.15), neonatal weight at birth  
(P = 0.000; β = 0.75; 95% CI 0.47- 1.03) and 
lactogenic medications (no vs. yes) (P = 0.020;  
β= -276.99; 95% CI 43.51- 510.48) remained in the 
model (Table 4). 
Discussion  
Although breastfeeding has been shown to be 
beneficial to mother and the newborn, many women 
are unsuccessful in their attempts. The Department of 
Health Infant Feeding Survey, 2000, indicated that 
only 69% of women giving birth in the United 
Kingdom attempted to breastfeed, and 39% were 
exclusively bottle feeding on discharge from hospital 
(21). These values are clearly higher in our study 
group even in two months after birth.  
Breast-feeding problems can be due to infant 
(palate structure) or maternal issues (inverted nipples, 
lack of education); there are many factors that are 
thought to influence the process (22, 23). We tried to 
exclude such confounders as much as possible. 
The use of pain killers has become increasingly 
popular for labor analgesia; however, their effects on 
breastfeeding remain unclear (24-25). Many studies 
have reported that opioids, particularly when used 
epidurally, cross the placenta and negatively influence 
the newborn’s neurobehavioral (6, 10, and 26). Others 
have reported that the pharmacological effects of these 
agents are responsible for the breastfeeding problem 
reported in these individuals (13). 
There are, however, contradictory reports 
regarding the impact of consuming these opioids on 
breast feeding (6, 24).  
Several studies have pointed out the negative 
influence of epidural analgesia on breastfeeding 
duration, stressing that the consumption of higher 
doses of fentanyl, which has high lipophilic and easily 
crosses the placenta, can lead to neonatal depression and 
negatively affect breastfeeding (27- 29). Torvaldsen et 
al, for instance, reported that women who had epidurals 
were less likely to fully breastfeed their infant in the few 
days after birth and more likely to stop breastfeeding in 
the first 24 weeks (30).  
The strongest evidence to date comes from a 
recent randomized controlled trial in which  
177 women who had previously breastfed were 
randomized to receive an epidural containing either 
no fentanyl, intermediate dose fentanyl (up to 150 μg 
fentanyl (or high dose fentanyl (> 150 μg fentanyl). 
Beilin et al reported that 65% of expectant mothers 
receiving more than 150μg of fentanyl epidurally are 
at a higher risk of nursing problems. They added that 
the risk is as low as 35% in those receiving lower 
doses of the drug (25). 
Wittels et al, on the other hand, reported a lower 
consciousness level in babies born to women who 
have received meperidine than those receiving 
morphine through Patient Control Analgesia (PCA) 
device (31). This could be confirmatory to our results 
about morphine. 
In line with the present study, three North 
American studies found no association between 
epidurals and breastfeeding duration (32-34).  
However, there are recently published reports 
about the safety of epidural or intrathecal opioids  
(17-19) and not obvious effect in the case of single 
dose systemic opioids (34). Even there is a report that 
suggesting successful lactation and safety for infant 
despite long term intrathecal morphine (35). Our 
result is also supporting these recent reports.     
The present study, for the first time, revealed that 
the use of spinal morphine does not have any impact 
on the breastfeeding. 
Meanwhile the low educational profile of our 
patients may have affected our results. It is therefore 
recommended to perform further studies in a broader 
group of individuals. 
It should be added that the present study also 
revealed that the number of gravid was the only 
factor influencing the impact of the administration of 
opioid route on the breastfeeding rate. Indicating that 
factors such as the maternal education, age, BMI, 
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profession, the infant’s birth weight and the use of 
products believed to improve the nursing did not 
affect the association. 
Based multivariate analysis using Logistic 
Regression test; male sexuality, and lactogenic 
medications were associated with more formula vs. 
sole Breastfeeding or combination feeding. 
In multivariate analysis using regression; non-
spinal group vs. Spinal, higher neonatal weight at 
birth had resulted higher weight at two month age, 
while lactogenic medications use was associated with 
lower weight at two month age. 
It seem that lactogenic medications had been used 
when there was breastfeeding problems, but such 
medications did not effective and neonatal weight  at 
two month age remain lower in this subgroup of 
patients. However, this hypothesis needs more studies 
to be documented. 
Neonates with higher weight at birth had higher 
weight in 2 month age but the mean difference 
diminished. There is not a clear hypothesis by authors to 
discuss the reason to lower weight in intrathecal opioid 
group, despite the equal rate of breastfeeding. However, 
it is so important issue and should be investigated. 
As a hypothesis and based on some social 
problems, higher rate of formula use in male infants 
may be the result of difference in sucking and 
behavioral characteristics related to gender or more 
probably related to gender discrimination by parents. 
This should be assessed in future studies. 
In view of the fact that various factors including 
the psychosomatic, environmental, socio-economic 
and cultural issues influence the breastfeeding, it was 
impossible to address the effect of all these variables 
in this study. Moreover, it was not feasible to visit all 
the mothers at the end of the month to assess the 
quality and quantity of breastfeeding or evaluating 
the mother and infant for possible problems. It is 
suggested that cultural and socioeconomic 
characteristics of our cases, had interfered with 
access to patients in our study group and result in 
high percentage of excluded cases. As a result, it 
would be beneficial to assess all the above mentioned 
variables in a larger study. 
Conclusion 
This is the first study which suggests that intrathecal 
morphine do not interfere with breastfeeding. The 
impacts of spinal anesthesia intrathecal morphine on 
weight gaining need more surveys to be clear. 
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